{
    "2020-08-26": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：第三批带量采购正式开标 创新仍是主旋律",
                "features": {
                    "keywords": [
                        "带量采购",
                        "创新",
                        "医药行业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "迈瑞董事长李西廷：坚持自主创新 增强全球研发实力",
                "features": {
                    "keywords": [
                        "迈瑞",
                        "自主创新",
                        "全球研发实力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-08-25",
                "original_text": "医疗器材行业的表现是今年股票市场的亮点之一。截止2020年8月25日，申万一级行业里的医药生物行业的涨幅排名第二，达53%。在申万三级行业里，医疗器械的涨幅为88%。",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "医药生物",
                        "涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械",
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗的心声：没有这块土壤，成就不了我们的今天",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "土壤",
                        "成就"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金动向盘点：反手加仓茅台，但“食药”持仓占比已达31.3%",
                "features": {
                    "keywords": [
                        "北向资金",
                        "茅台",
                        "食药",
                        "持仓占比"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品饮料",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}